Pathophysiology and Management of Cerebral Venous Thrombosis

Cerebral venous thrombosis (CVT) is a less common type of stroke that can occur across all age groups but predominantly affects children and young adults. Diagnosis is often challenging due to the nonspecific and variable clinical presentation. The disease course is heterogeneous, with CVT-related parenchymal lesions developing in approximately 50 to 60% of cases. Despite some advancements, significant gaps persist in understanding the pathophysiology of CVT, including the mechanisms underlying brain injury. Anticoagulation is the cornerstone of CVT treatment, but strategies targeting secondary mechanisms of parenchymal damage are still lacking. Here, the current state of the field is briefly reviewed, with the aim to introduce a wide audience (neuroscientists and clinicians alike) to the disease and inform clinical practice and future research.

Authors

Institutions

Publication Details

Journal
Hämostaseologie
Published
2025-04-08
DOI
https://doi.org/10.1055/a-2518-9103
Citations
2
Primary Topic
Cerebral Venous Sinus Thrombosis
Type
article
Field-Weighted Citation Impact
2.78
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pathophysiology and Management of Cerebral Venous Thrombosis

Mariana B. Morais, Diana Aguiar de Sousa
2 citations
Hämostaseologie
Cerebral Venous Sinus Thrombosis
2.78
article

Pathophysiology and Management of Cerebral Venous Thrombosis

Mariana B. Morais, Diana Aguiar de Sousa
article en
2 citations

Abstract

Cerebral venous thrombosis (CVT) is a less common type of stroke that can occur across all age groups but predominantly affects children and young adults. Diagnosis is often challenging due to the nonspecific and variable clinical presentation. The disease course is heterogeneous, with CVT-related parenchymal lesions developing in approximately 50 to 60% of cases. Despite some advancements, significant gaps persist in understanding the pathophysiology of CVT, including the mechanisms underlying brain injury. Anticoagulation is the cornerstone of CVT treatment, but strategies targeting secondary mechanisms of parenchymal damage are still lacking. Here, the current state of the field is briefly reviewed, with the aim to introduce a wide audience (neuroscientists and clinicians alike) to the disease and inform clinical practice and future research.

HämostaseologieVol. 45(04)
University of Lisbon (PT), Hospital de São José (PT), Instituto Gulbenkian de Ciência (PT)
Good health and well-being
Openalex Percentile: Top 11%
Cerebral Venous Sinus Thrombosis
2.78
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pathophysiology and Management of Cerebral Venous Thrombosis — Mariana B. Morais, Diana Aguiar de Sousa · Hämostaseologie (2025) | TGRS Research Map | TGRS